Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With GC/GEJ and High Immune Responsiveness
Clinical trial NCT03421288 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03421288
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-14
- Primary completion
- 2027-05-31
- Enrollment
- 677
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.